Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-trace').style.display = (document.getElementById('cakeErr6801c5829f340-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6801c5829f340-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-code').style.display = (document.getElementById('cakeErr6801c5829f340-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-context').style.display = (document.getElementById('cakeErr6801c5829f340-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6801c5829f340-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6801c5829f340-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 19136,
		&#039;title&#039; =&gt; &#039;Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Live Mint&lt;br /&gt;
&lt;br /&gt;
Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;
&lt;br /&gt;
The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Activists dismissed such concerns.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 7 February, 2013, http://www.livemint.com/Industry/Z7SPMRvBh9Ap1sxo8iOcGI/Government-tightens-guidelines-for-clinical-trials.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 19271,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 19136,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Clinical Trials,medicines,Law and Justice,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-Live Mint

Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-Live Mint&lt;br /&gt;&lt;br /&gt;Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;&lt;br /&gt;The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Activists dismissed such concerns.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 19136,
	&#039;title&#039; =&gt; &#039;Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Live Mint&lt;br /&gt;
&lt;br /&gt;
Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;
&lt;br /&gt;
The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Activists dismissed such concerns.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 7 February, 2013, http://www.livemint.com/Industry/Z7SPMRvBh9Ap1sxo8iOcGI/Government-tightens-guidelines-for-clinical-trials.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 19271,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 19136
$metaTitle = &#039;LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;
$metaKeywords = &#039;Clinical Trials,medicines,Law and Justice,Health&#039;
$metaDesc = &#039;
-Live Mint

Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-Live Mint&lt;br /&gt;&lt;br /&gt;Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;&lt;br /&gt;The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Activists dismissed such concerns.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy | Im4change.org</title>
    <meta name="description" content="
-Live Mint

Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-Live Mint<br /><br />Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act <br /><br />The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.<br /></div><div align="justify">&nbsp;</div><div align="justify">The developments are a part of reforms in clinical trials initiated after the Supreme Court&rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.<br /></div><div align="justify">&nbsp;</div><div align="justify">In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&rdquo;.<br /></div><div align="justify">&nbsp;</div><div align="justify">Crucially, if the drug being tested fails to improve a patient&rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&rsquo;s child while she is participating in a clinical trial.<br /></div><div align="justify">&nbsp;</div><div align="justify">The new norms would be extended even to the so-called placebo-controlled trials.<br /></div><div align="justify">&nbsp;</div><div align="justify">Placebos, or &ldquo;sugar pills&rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&rsquo;s condition to the drug being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.<br /></div><div align="justify">&nbsp;</div><div align="justify">Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&rsquo;s (CSIR&rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &ldquo;I haven&rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&rsquo;t know how you can replace it,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.<br /></div><div align="justify">&nbsp;</div><div align="justify">Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &lsquo;as long as required&rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">Activists dismissed such concerns.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&rdquo; he added.<br /></div><div align="justify">&nbsp;</div><div align="justify">According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &ldquo;new chemical entities not approved as drugs for human use anywhere in the world&rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-trace').style.display = (document.getElementById('cakeErr6801c5829f340-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6801c5829f340-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-code').style.display = (document.getElementById('cakeErr6801c5829f340-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-context').style.display = (document.getElementById('cakeErr6801c5829f340-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6801c5829f340-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6801c5829f340-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 19136,
		&#039;title&#039; =&gt; &#039;Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Live Mint&lt;br /&gt;
&lt;br /&gt;
Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;
&lt;br /&gt;
The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Activists dismissed such concerns.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 7 February, 2013, http://www.livemint.com/Industry/Z7SPMRvBh9Ap1sxo8iOcGI/Government-tightens-guidelines-for-clinical-trials.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 19271,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 19136,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Clinical Trials,medicines,Law and Justice,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-Live Mint

Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-Live Mint&lt;br /&gt;&lt;br /&gt;Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;&lt;br /&gt;The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Activists dismissed such concerns.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 19136,
	&#039;title&#039; =&gt; &#039;Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Live Mint&lt;br /&gt;
&lt;br /&gt;
Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;
&lt;br /&gt;
The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Activists dismissed such concerns.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 7 February, 2013, http://www.livemint.com/Industry/Z7SPMRvBh9Ap1sxo8iOcGI/Government-tightens-guidelines-for-clinical-trials.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 19271,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 19136
$metaTitle = &#039;LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;
$metaKeywords = &#039;Clinical Trials,medicines,Law and Justice,Health&#039;
$metaDesc = &#039;
-Live Mint

Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-Live Mint&lt;br /&gt;&lt;br /&gt;Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;&lt;br /&gt;The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Activists dismissed such concerns.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy | Im4change.org</title>
    <meta name="description" content="
-Live Mint

Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-Live Mint<br /><br />Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act <br /><br />The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.<br /></div><div align="justify">&nbsp;</div><div align="justify">The developments are a part of reforms in clinical trials initiated after the Supreme Court&rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.<br /></div><div align="justify">&nbsp;</div><div align="justify">In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&rdquo;.<br /></div><div align="justify">&nbsp;</div><div align="justify">Crucially, if the drug being tested fails to improve a patient&rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&rsquo;s child while she is participating in a clinical trial.<br /></div><div align="justify">&nbsp;</div><div align="justify">The new norms would be extended even to the so-called placebo-controlled trials.<br /></div><div align="justify">&nbsp;</div><div align="justify">Placebos, or &ldquo;sugar pills&rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&rsquo;s condition to the drug being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.<br /></div><div align="justify">&nbsp;</div><div align="justify">Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&rsquo;s (CSIR&rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &ldquo;I haven&rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&rsquo;t know how you can replace it,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.<br /></div><div align="justify">&nbsp;</div><div align="justify">Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &lsquo;as long as required&rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">Activists dismissed such concerns.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&rdquo; he added.<br /></div><div align="justify">&nbsp;</div><div align="justify">According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &ldquo;new chemical entities not approved as drugs for human use anywhere in the world&rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-trace').style.display = (document.getElementById('cakeErr6801c5829f340-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6801c5829f340-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-code').style.display = (document.getElementById('cakeErr6801c5829f340-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6801c5829f340-context').style.display = (document.getElementById('cakeErr6801c5829f340-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6801c5829f340-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6801c5829f340-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 19136,
		&#039;title&#039; =&gt; &#039;Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Live Mint&lt;br /&gt;
&lt;br /&gt;
Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;
&lt;br /&gt;
The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Activists dismissed such concerns.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 7 February, 2013, http://www.livemint.com/Industry/Z7SPMRvBh9Ap1sxo8iOcGI/Government-tightens-guidelines-for-clinical-trials.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 19271,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 19136,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Clinical Trials,medicines,Law and Justice,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-Live Mint

Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-Live Mint&lt;br /&gt;&lt;br /&gt;Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;&lt;br /&gt;The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Activists dismissed such concerns.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 19136,
	&#039;title&#039; =&gt; &#039;Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Live Mint&lt;br /&gt;
&lt;br /&gt;
Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;
&lt;br /&gt;
The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
Activists dismissed such concerns.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 7 February, 2013, http://www.livemint.com/Industry/Z7SPMRvBh9Ap1sxo8iOcGI/Government-tightens-guidelines-for-clinical-trials.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 19271,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 19136
$metaTitle = &#039;LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy&#039;
$metaKeywords = &#039;Clinical Trials,medicines,Law and Justice,Health&#039;
$metaDesc = &#039;
-Live Mint

Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-Live Mint&lt;br /&gt;&lt;br /&gt;Developments a part of reforms initiated after apex court&amp;rsquo;s intervention to amend Drugs and Cosmetics Act &lt;br /&gt;&lt;br /&gt;The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The developments are a part of reforms in clinical trials initiated after the Supreme Court&amp;rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &amp;ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&amp;rdquo;.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Crucially, if the drug being tested fails to improve a patient&amp;rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&amp;rsquo;s child while she is participating in a clinical trial.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;The new norms would be extended even to the so-called placebo-controlled trials.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Placebos, or &amp;ldquo;sugar pills&amp;rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&amp;rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&amp;rsquo;s condition to the drug being tested.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&amp;rsquo;s (CSIR&amp;rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &amp;ldquo;I haven&amp;rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&amp;rsquo;t know how you can replace it,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&amp;rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &amp;lsquo;as long as required&amp;rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&amp;rdquo; he said.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;Activists dismissed such concerns.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&amp;rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&amp;rdquo; he added.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &amp;ldquo;new chemical entities not approved as drugs for human use anywhere in the world&amp;rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy | Im4change.org</title>
    <meta name="description" content="
-Live Mint

Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-Live Mint<br /><br />Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act <br /><br />The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.<br /></div><div align="justify">&nbsp;</div><div align="justify">The developments are a part of reforms in clinical trials initiated after the Supreme Court&rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.<br /></div><div align="justify">&nbsp;</div><div align="justify">In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&rdquo;.<br /></div><div align="justify">&nbsp;</div><div align="justify">Crucially, if the drug being tested fails to improve a patient&rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&rsquo;s child while she is participating in a clinical trial.<br /></div><div align="justify">&nbsp;</div><div align="justify">The new norms would be extended even to the so-called placebo-controlled trials.<br /></div><div align="justify">&nbsp;</div><div align="justify">Placebos, or &ldquo;sugar pills&rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&rsquo;s condition to the drug being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.<br /></div><div align="justify">&nbsp;</div><div align="justify">Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&rsquo;s (CSIR&rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &ldquo;I haven&rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&rsquo;t know how you can replace it,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.<br /></div><div align="justify">&nbsp;</div><div align="justify">Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &lsquo;as long as required&rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">Activists dismissed such concerns.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&rdquo; he added.<br /></div><div align="justify">&nbsp;</div><div align="justify">According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &ldquo;new chemical entities not approved as drugs for human use anywhere in the world&rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 19136,
		'title' => 'Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy',
		'subheading' => '',
		'description' => '<div align="justify">
-Live Mint<br />
<br />
Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act <br />
<br />
The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
The developments are a part of reforms in clinical trials initiated after the Supreme Court&rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&rdquo;.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Crucially, if the drug being tested fails to improve a patient&rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&rsquo;s child while she is participating in a clinical trial.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
The new norms would be extended even to the so-called placebo-controlled trials.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Placebos, or &ldquo;sugar pills&rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&rsquo;s condition to the drug being tested.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&rsquo;s (CSIR&rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &ldquo;I haven&rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&rsquo;t know how you can replace it,&rdquo; he said.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &lsquo;as long as required&rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&rdquo; he said.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Activists dismissed such concerns.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&rdquo; he added.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &ldquo;new chemical entities not approved as drugs for human use anywhere in the world&rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.
</div>',
		'credit_writer' => 'Live Mint, 7 February, 2013, http://www.livemint.com/Industry/Z7SPMRvBh9Ap1sxo8iOcGI/Government-tightens-guidelines-for-clinical-trials.html',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 19271,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 19136,
	'metaTitle' => 'LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy',
	'metaKeywords' => 'Clinical Trials,medicines,Law and Justice,Health',
	'metaDesc' => '
-Live Mint

Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury...',
	'disp' => '<div align="justify">-Live Mint<br /><br />Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act <br /><br />The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.<br /></div><div align="justify">&nbsp;</div><div align="justify">The developments are a part of reforms in clinical trials initiated after the Supreme Court&rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.<br /></div><div align="justify">&nbsp;</div><div align="justify">In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&rdquo;.<br /></div><div align="justify">&nbsp;</div><div align="justify">Crucially, if the drug being tested fails to improve a patient&rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&rsquo;s child while she is participating in a clinical trial.<br /></div><div align="justify">&nbsp;</div><div align="justify">The new norms would be extended even to the so-called placebo-controlled trials.<br /></div><div align="justify">&nbsp;</div><div align="justify">Placebos, or &ldquo;sugar pills&rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&rsquo;s condition to the drug being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.<br /></div><div align="justify">&nbsp;</div><div align="justify">Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&rsquo;s (CSIR&rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &ldquo;I haven&rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&rsquo;t know how you can replace it,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.<br /></div><div align="justify">&nbsp;</div><div align="justify">Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &lsquo;as long as required&rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">Activists dismissed such concerns.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&rdquo; he added.<br /></div><div align="justify">&nbsp;</div><div align="justify">According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &ldquo;new chemical entities not approved as drugs for human use anywhere in the world&rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 19136,
	'title' => 'Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy',
	'subheading' => '',
	'description' => '<div align="justify">
-Live Mint<br />
<br />
Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act <br />
<br />
The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
The developments are a part of reforms in clinical trials initiated after the Supreme Court&rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&rdquo;.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Crucially, if the drug being tested fails to improve a patient&rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&rsquo;s child while she is participating in a clinical trial.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
The new norms would be extended even to the so-called placebo-controlled trials.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Placebos, or &ldquo;sugar pills&rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&rsquo;s condition to the drug being tested.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&rsquo;s (CSIR&rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &ldquo;I haven&rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&rsquo;t know how you can replace it,&rdquo; he said.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &lsquo;as long as required&rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&rdquo; he said.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
Activists dismissed such concerns.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&rdquo; he added.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &ldquo;new chemical entities not approved as drugs for human use anywhere in the world&rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.
</div>',
	'credit_writer' => 'Live Mint, 7 February, 2013, http://www.livemint.com/Industry/Z7SPMRvBh9Ap1sxo8iOcGI/Government-tightens-guidelines-for-clinical-trials.html',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'government-tightens-guidelines-for-clinical-trials-vidya-krishnan-and-jacob-p-koshy-19271',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 19271,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 19136
$metaTitle = 'LATEST NEWS UPDATES | Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy'
$metaKeywords = 'Clinical Trials,medicines,Law and Justice,Health'
$metaDesc = '
-Live Mint

Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act 

The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury...'
$disp = '<div align="justify">-Live Mint<br /><br />Developments a part of reforms initiated after apex court&rsquo;s intervention to amend Drugs and Cosmetics Act <br /><br />The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.<br /></div><div align="justify">&nbsp;</div><div align="justify">The developments are a part of reforms in clinical trials initiated after the Supreme Court&rsquo;s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.<br /></div><div align="justify">&nbsp;</div><div align="justify">In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in &ldquo;the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required&rdquo;.<br /></div><div align="justify">&nbsp;</div><div align="justify">Crucially, if the drug being tested fails to improve a patient&rsquo;s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman&rsquo;s child while she is participating in a clinical trial.<br /></div><div align="justify">&nbsp;</div><div align="justify">The new norms would be extended even to the so-called placebo-controlled trials.<br /></div><div align="justify">&nbsp;</div><div align="justify">Placebos, or &ldquo;sugar pills&rdquo;, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don&rsquo;t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient&rsquo;s condition to the drug being tested.<br /></div><div align="justify">&nbsp;</div><div align="justify">Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.<br /></div><div align="justify">&nbsp;</div><div align="justify">Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research&rsquo;s (CSIR&rsquo;s) open source drug discovery project, said the use of a placebo was central to a drug trial. &ldquo;I haven&rsquo;t read the notification, but a placebo is essential to the conduct of any trial and I don&rsquo;t know how you can replace it,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.<br /></div><div align="justify">&nbsp;</div><div align="justify">Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,&rdquo; said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions &lsquo;as long as required&rsquo;. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,&rdquo; he said.<br /></div><div align="justify">&nbsp;</div><div align="justify">Activists dismissed such concerns.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,&rdquo; said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,&rdquo; he added.<br /></div><div align="justify">&nbsp;</div><div align="justify">According to documents submitted by the health ministry in the apex court, 475 human clinical trials for &ldquo;new chemical entities not approved as drugs for human use anywhere in the world&rdquo; were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Government tightens guidelines for clinical trials-Vidya Krishnan and Jacob P Koshy

-Live Mint Developments a part of reforms initiated after apex court’s intervention to amend Drugs and Cosmetics Act The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.   So far, the compensation has been restricted only to cases where the medication being tested had caused either injury or death. The gazette notification, issued on 30 January, could potentially make clinical trials in India more expensive.   The developments are a part of reforms in clinical trials initiated after the Supreme Court’s intervention to amend the Drugs and Cosmetics Act. Earlier this month, the apex court had directed the health ministry to monitor all clinical trials, revoking the powers of the Central Drugs Standard Control Organization.   In a drastic shift from the present scenario wherein only physical injuries are compensated for after establishing a direct connection with trial drugs, the notification states that in “the case of an injury occurring to the clinical trial subject, he or she shall be given free medical management as long as required”.   Crucially, if the drug being tested fails to improve a patient’s condition or causes adverse effects, the company would be liable to compensate the patient. Similarly, companies would have to compensate for any harm suffered by a pregnant woman’s child while she is participating in a clinical trial.   The new norms would be extended even to the so-called placebo-controlled trials.   Placebos, or “sugar pills”, are part of a standard clinical trial practice in which a few out of a group of patients who consent to being part of a trial don’t receive the drug being tested, but are instead given a harmless pill. This is done to measure the effectiveness of a drug by comparing the condition of patients taking the therapy and those being administered the placebos, and to isolate improvement in a patient’s condition to the drug being tested.   Given that the number of tested drugs that fail far exceeds the successful ones and most trials use a placebo, the number of patients who would be potentially compensated under the new rules will be much higher.   Zakir Thomas, who coordinates the government-run Council of Scientific and Industrial Research’s (CSIR’s) open source drug discovery project, said the use of a placebo was central to a drug trial. “I haven’t read the notification, but a placebo is essential to the conduct of any trial and I don’t know how you can replace it,” he said.   CSIR in the future hopes to be able to test new molecules to make tuberculosis drugs.   Industry experts maintain that any trial subject could be eligible for compensation under the factors listed because of lack of clarity in the document.   “The notification covers every category of patients without making the distinction between trial-related and non-trial related injuries,” said Arun Bhatt, a member of the executive committee at the Indian Society for Clinical Research.   “The notification requires more clarity. Who will decide the period of free medical treatment? The notification simply mentions ‘as long as required’. Earlier injuries meant only physical injuries. This leaves room for all (kinds of) claims. Besides the industry, this will hurt individual doctors and institutions conducting trials,” he said.   Activists dismissed such concerns.   “Most clinical trials are multi-centred and spread across countries. It is unfair that Indian trial subjects should get compensated on the basis of their minimum wages while subjects of the same trial in developed countries get significant amounts of compensation to rehabilitate them for life,” said Amulya Nidhi, an activist with the Swasthya Adhikar Manch and a petitioner in the Supreme Court case.   “The move to treat any injury as trial-related is welcome as certain amount of liability has to be placed on sponsors and investigators. So far, it has been extremely challenging to attribute any injury or death directly to the trial because there are no guidelines to establish the link. This is in the best interest of trial subjects,” he added.   According to documents submitted by the health ministry in the apex court, 475 human clinical trials for “new chemical entities not approved as drugs for human use anywhere in the world” were approved by the Indian drug regulator between January 2005 and 30 June 2012. Out of the 475 experimental drugs, 17 have been given approval for marketing, according to court records. During the period, 11,972 serious adverse events, excluding deaths, were reported, out of which 506 have been attributed to clinical trials. None of the victims has been compensated.